1. Home
  2. BSET vs IMUX Comparison

BSET vs IMUX Comparison

Compare BSET & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$22.01

Market Cap

181.2M

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$7.20

Market Cap

155.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSET
IMUX
Founded
1902
2016
Country
United States
United States
Employees
N/A
66
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
181.2M
155.8M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
BSET
IMUX
Price
$22.01
$7.20
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $43.09
AVG Volume (30 Days)
25.1K
★ 392.8K
Earning Date
09-30-2026
11-12-2026
Dividend Yield
★ 3.72%
N/A
EPS Growth
★ 163.06
38.00
EPS
★ 0.61
N/A
Revenue
★ $456,855,000.00
N/A
Revenue This Year
$0.85
N/A
Revenue Next Year
$3.42
N/A
P/E Ratio
$35.49
★ N/A
Revenue Growth
★ 0.96
N/A
52 Week Low
$13.17
$0.51
52 Week High
$22.26
$17.43

Technical Indicators

Market Signals
Indicator
BSET
IMUX
Relative Strength Index (RSI) 69.13 33.34
Support Level $13.90 $6.35
Resistance Level $22.26 $8.60
Average True Range (ATR) 0.83 0.65
MACD 0.06 0.17
Stochastic Oscillator 91.35 36.89

Price Performance

Historical Comparison
BSET
IMUX

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: